Is Cintas Stock Underperforming the Nasdaq? - Barchart.com
π CTAS reported Q4 adjusted EPS of $1.29, beating analyst expectations of $1.24.
π° Revenue for the quarter reached $2.91 billion, exceeding forecasts of $2.88 billion.
π The company provided full-year guidance for adjusted EPS between $5.36 and $5.50.
π Shares slipped 8.3% from their 52-week high of $219.16 despite strong fundamentals.
βοΈ Investors are cautious regarding pending FTC regulatory reviews on the company's operations.
π€ Integration risks surrounding the pending acquisition of UniFirst Corporation cap equity upside.
π The stock trades above its 50-day and 200-day moving averages since June and July respectively.
π Wall Street analysts hold a consensus 'Moderate Buy' rating with 20 covers.
π― The mean analyst price target is $217.44, implying an 8.2% upside from current levels.
- CTAS delivered a Q4 adjusted EPS beat of $1.29 versus the $1.24 consensus estimate.
- Revenue of $2.91 billion exceeded Wall Street forecasts of $2.88 billion, demonstrating strong demand.
- The company provided full-year guidance for adjusted EPS in the range of $5.36 to $5.50.
- Full-year revenue is expected to fall between $12.1 billion and $12.3 billion.
- Shares have traded above both the 50-day and 200-day moving averages since early June and mid-July.
- Wall Street analysts maintain a consensus 'Moderate Buy' rating with a mean price target of $217.44.
- Shares slipped 8.3% from their 52-week high of $219.16, indicating recent weakness.
- The stock underperformed the Nasdaq Composite over the past year with a 23.7% return gap.
- Investor caution regarding FTC regulatory reviews is capping equity upside despite operational strength.
- Integration risks associated with the pending UniFirst Corporation acquisition pose potential headwinds.